Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1621-1629

  Bronner, Stéphane ^a   Jehl, François ^a   Peter, Jean Daniel ^a   Ploy, Marie Cécile ^b   Renault, Corinne ^a   Arvis, Pierre ^c   Monteil, Henri ^a   Prevost, Gilles ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c Bayer Pharma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTOXIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PENETRATION; ENDOPHTHALMITIS; EYE INJURY; EYE SURGERY; FEMALE; GENE EXPRESSION; INFLAMMATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; TOXIN SYNTHESIS; VITREOUS BODY;

ANIMALS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; ENDOPHTHALMITIS; EXOTOXINS; FEMALE; FLUOROQUINOLONES; MALE; MICROBIAL SENSITIVITY TESTS; QUINOLINES; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 0038673551     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1621-1629.2003     Document Type: Article

References (46)

1. Alfaro, D. V., S. J. Hudson, M. M. Rafanan, S. T. Moss, and S.-D. P. Levy. 1996. The effect of trauma on the ocular penetration of intravenous ciprofloxacin, Am. J. Ophthalmol. 122:678-683.
2. Araujo, F. G., T. L. Slifer, and J. S. Remington. 2002. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin. Microbiol. Infect. 8:26-30.
3. Augustin, J. R., R. Rosenstein, B. Wieland, U. Schneider, N. Schnell, G. Engelke, K. D. Entian, and F. Götz. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149-1154.
4. Berrington, A. W., J. D. Perry, and F. K. Gould. 2001. Bactericidal activity of moxifloxacin against Staphylococcus aureus. Clin. Microbiol. Infect. 7:161-163.
5. Bisognano, C., P. Vaudaux, P. Rohner, D. P. Lew, and D. C. Hooper. 2000. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 44:1428-1437.
6. Booth, M. C., A. L. Cheung, K. L. Hatter, B. D. Jett, M. C. Callegan, and M. S. Gilmore. 1997. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect. Immun. 65:1550-1556.
7. Boswell, F. J., J. M. Andrews, and R. Wise. 1997. Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect. Antimicrob. Agents Chemother. 41:1377-1379.
8. Bronner, S., P. Stoessel, A. Gravet, H. Monteil, and G. Prévost. 2000. Variable expressions of Staphylococcus aureus bicomponent leucotoxins semiquantified by competitive reverse transcription-PCR. Appl. Environ. Microbiol. 66:3931-3938.
9. Brueggemann, A. B., K. C. Kugler, and G. V. Doern. 1997. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 41:1594-1597.
10. Callegan, M. C., L. S. Engel, J. M. Hill, and R. J. O'Callaghan. 1994. Corneal virulence of Staphylococcus aureus: roles of α-toxin and protein A in pathogenesis. Infect. Immun. 62:2478-2482.
11. Callegan, M. C., M. Engelbert, D. W. Parke II, B. D. Jett, and M. S. Gilmore. 2002. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin. Microbiol. Rev. 15:111-124.
12. Cheung, A. L., M. Koomey, C. A. Butler, S. J. Projan, and V. A. Fischetti. 1992. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 89:6462-6466.
13. Cunha-Vaz, J. 1980. Sites and functions of the blood-retinal barriers, p. 101-117. In Cunha-Vaz (ed.), Blood-retinal barrier. Plenum Press, New York, N.Y.
14. Dunman, P. M., E. Murphy, S. Haney, D. Palacios, G. Tucker-Kellogg, S. Wu, E. L. Brown, R. J. Zagursky, D. Shlaes, and S. J. Projan. 2001. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183:7341-7353.
15. Ferencz, J. R., E. I. Assia, L. Diamanstein, and E. Rubinstein. 1999. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch. Ophthalmol. 117:1023-1027.
16. Garcia-Sáenz, M. C., A. Arias-Puente, M. J. Fresnadillo-Martinez, and C. Carrasco-Font. 2001. Human aqueous humor levels of oral ciprofloxacin, levofluxacin, and moxifloxacin. J. Cataract Refract. Surg. 27:1969-1974.
17. Gibaldi, M., and D. Perrier. 1982. Drug and pharmaceutical sciences: pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
18. - versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis. Curr. Eye Res. 18:177-185.
19. Goerke, C., U. Fluckiger, A. Steinhuber, W. Zimmerli, and C. Woltz. 2001. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of α-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol. Microbiol. 40:1439-1447.
20. Gravet, A., D. A. Colin, D. Keller, R. Girardot, H. Monteil, and G. Prévost. 1998. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 436:202-208.
21. Gravet, A., M. Rondeau, C. Harf-Monteil, F. Grunenberger, H. Monteil, J. M. Scheftel, and G. Prévost. 1999. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-LukD. J. Clin. Microbiol. 37:4012-4019.
22. Henderson, B., and M. Wilson. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8:269-282.
23. Herbert, S., P. Barry, and R. P. Novick. 2001. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun. 69:2996-3003.
24. Hoogkamp-Korstanje, J. A. A., and J. Roelofs-Willemse. 2000. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J. Antimicrob. Chemother. 45:31-39.
25. Jones, M. E., M. R. Visser, M. Klootwijk, P. Heisig, J. Verhoef, and F. J. Schmitz. 1999. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains. Antimicrob. Agents Chemother. 43:421-423.
26. Kernodle, D. S., P. A. McGraw, N. L. Barg, B. E. Menzies, R. K. R. Voladri, and S. Harshman. 1995. Growth of Staphylococcus aureus with naficillin in vitro induces α-toxin production and increases the lethal activity of sterile broth filtrates in a murine model. J. Infect. Dis. 172:410-419.
27. Krüll, M., C. Dold, S. Hippenstiel, S. Rousseau, J. Lohmeyer, and N. Suttorp. 1996. Escherichia coli hemolysin and Staphylococcus aureus α-toxin potently induce neutrophil adhesion to cultured human endothelial cells. J. Immunol. 157:4133-4140.
28. Liu, W., Q. F. Liu, R. Perkins, G. Drusano, A. Louie, A. Madu, U. Mian, M. Mayers, and M. H. Miller. 1998. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials. Antimicrob. Agents Chemother. 42:1417-1423.
29. Mather, M., L. M. Karenchak, E. G. Romanowski, and R. P. Kowalski. 2002. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am. J. Ophthalmol. 133:463-466.
30. Moreau, J. M., G. M. Sloop, L. S. Engel, J. M. Hill, and R. J. O'Callaghan. 1997. Histopathological studies of staphylococcal α-toxin: effects on rabbit corneas. Curr. Eye Res. 16:1221-1228.
31. Morlet, N., G. G. Graham, B. Gatus, A. J. McLachlan, C. Salonikas, D. Naidoo, I. Goldberg, and C. Man Lam. 2000. Pharmacokinetics of ciprofloxacin in the human eye: a clinical and population pharmacokinetic analysis. Antimicrob. Agents Chemother. 44:1674-1679.
32. Müller, M., H. Stass, M. Brunner, J. G. Möller, E. Lackner, and H. G. Eichler. 1999. Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob. Agents Chemother. 43:2345-2349.
33. Nau, R., and H. Eiffert. 2002. Modulation of release of proinflammatory bacterial componds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningititis. Clin. Microbiol. Rev. 15:95-110.
34. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
35. Nussenblatt, R. B., A. G. Palestine, C. C. Chan, and F. Roberge. 1985. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 98:467-471.
36. O'Callaghan, R. J., M. C. Callegan, J. M. Moreau, L. C. Green, T. J. Foster, O. M. Hatford, L. S. Engel, and J. M. Hill. 1997. Specific roles of α-toxin and β-toxin during Staphylococcus aureus corneal infection. Infect. Immun. 65:1571-1578.
37. Olshen, K., W. Ziebuhr, K. P. Koller, W. Hell, T. A. Wichelhaus, and J. Hacker. 1998. Effect of subinhibitory concentrations of antibiotics on alphatoxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Infect. Immun. 42:2817-2823.
38. Ostergaard, C., T. K. Sorensen, J. D. Knudsen, and N. Frimodt-Moller. 1998. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob. Agents Chemother. 42:1706-1712.
39. Perkins, R. J., W. Liu, G. Drusano, A. Madu, M. Mayers, C. Madu, and M. H. Miller. 1995. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents Chemother. 39:1493-1498.
40. Prévost, G., B. Cribier, P. Couppié, P. Petiau, G. Supersac, V. Finck-Barbançon, H. Monteil, and Y. Piémont. 1995. Panton-Valentine leucocidin and γ-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63:4121-4129.
41. Schmidt, H., A. Dalhoff, K. Stuertz, F. Trostdorf, V. Chien, O. Schneider, C. Kohlsdorfer, W. Brück, and R. Nau. 1998. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob. Agents Chemother. 42:1397-1401.
42. Siqueira, J. A., C. Speeg-Schatz, F. I. S. Freitas, J. Sahel, H. Monteil, and G. Prévost. 1997. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J. Med. Microbiol. 46:1-9.
43. Smith, A., P. M. Pennefather, S. B. Kaye, and C. A. Hart. 2001. Fluoroquinolones: place in ocular therapy. Drugs 61:747-761.
44. Supersac, G., Y. Piémont, M. Kubina, G. Prévost, and T. J. Foster. 1998. Assessment of the role of γ-toxin in experimental endophthalmitis using a hlg deficient mutant of Staphylococcus aureus. Microb. Pathog. 24:241-251.
45. Wise, R., J. M. Andrews, G. Marshall, and G. Hartman. 1999. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration. Antimicrob. Agents Chemother. 43:1508-1510.
46. Worlitzsch, D., H. Kaygin, A. Steinhuber, A. Dalhoff, K. Botzenhart, and G. Döring. 2001. Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo. Antimicrob. Agents Chemother. 45:196-202.